AnandRathi

Piramal Pharma Ltd Share Price

Last Updated Date: 27 Aug 2026
214.90
+3.45 (+1.63%)

As of 28 Aug 2026, Piramal Pharma Ltd share price is ₹214.90. The stock opened at ₹214.90 and had closed at ₹211.45 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹132.50 and a high of ₹220.40. In terms of performance, Piramal Pharma Ltd share price has increased by 33.52% over the past six months and has increased by 17.05% over the last year.

PPLPHARMA Charts

Piramal Pharma Ltd Overview

Market cap₹28,611 Crs
Volume3,90,024
Prev. Close₹211.45
Year range₹132.50 - ₹220.40
Total Value₹8,38,16,157.60
ISININE0DK501011

About PPLPHARMA

Piramal Pharma is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. We operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (“CDMO”) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (“APIs”), Finished dosage forms (“FDFs”), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (“CHG“) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and Piramal Consumer Healthcare (“PCH“) business, selling well-known OTC brands.

Piramal Pharma Ltd Historical Performance

1 Month Return11.90%
6 Month Return37.62%
3 Year Return113.09%
3 Month Return23.36%
1 Year Return13.55%
5 Year Return-

Piramal Pharma Ltd Fundamental Analysis

ROCE(TTM)11.75%
P/E Ratio (TTM)40.86
P/B Ratio3.51
Debt to Equity0.10
ROE9.51%
EPS (TTM)5.82
Dividend Yield0.00%
Book Value61.18
Profit Margin15.69%
Operating Margin9.17%

Piramal Pharma Ltd Financials

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25
Revenue1,239.581,672.751,291.961,329.231,150.80
EBITDA231.57421.47236.46329.04225.25
Net Profit113.48261.63128.91196.33113.14
EPS0.851.970.971.480.85

Piramal Pharma Ltd Technical Analysis

IndicatorValue
RSI60.63
MACD6.67
20-Day SMA208.02

Piramal Pharma Ltd Corporate Actions

Corporate ActionEx DateRecord Date
No forthcoming board meetings available.

Piramal Pharma Ltd Peer Comparison

CompanyPriceM.Cap (Cr)P/E (TTM)ROE (TTM)
Sun Pharmaceutical Industries LtdSUNPHARMA
1,913.30+0.73%
4,19,727.6638.3213.74%
Divis Laboratories LtdDIVISLAB
9,060.00+0.39%
1,67,235.9167.4615.32%
Torrent Pharmaceuticals LtdTORNTPHARM
4,999.00+2.23%
1,46,951.3264.6825.49%

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research